Sunstein LLP has elevated patent attorney Christopher Lacenere, Ph.D. to Partner. Christopher focuses his practice on biotech and life sciences matters involving both patent prosecution and litigation. He has particular experience in genetics, next-generation sequencing, cellular and molecular biology, biochemistry, and molecular diagnostics.

“Congratulations to Christopher on his well-deserved promotion to Partner,” said Sunstein Partner and Patent Practice Group Leader, John W. Powell. “We are proud of his accomplishments and industry involvement, and are excited to watch him continue to contribute to the success of our clients and our firm.”

In helping clients develop robust patent portfolios, Christopher draws on his deep technical knowledge, patent prosecution experience, and his experience performing sophisticated analyses of complex patent portfolios in litigations. He is registered to practice as a patent attorney before the United States Patent and Trademark Office.

In addition to his significant patent prosecution experience, Christopher has worked with litigators and expert witnesses on the technical aspects of patent litigation, claim construction, patent invalidity, and infringement. His doctoral research included the development of new nucleic acid sequencing technologies. Christopher also has industry experience in validating the bioactivity of therapeutic drug candidate leads and evaluating high-throughput screening technologies.

He earned his J.D. (cum laude) from Suffolk University Law School, holds a Ph.D. in biology from the California Institute of Technology and a bachelor’s degree in biological sciences (with honors) from Carnegie Mellon University.